HS-10296
CAS No. 1899921-05-1
HS-10296( —— )
Catalog No. M20205 CAS No. 1899921-05-1
Hs-10296 is an inhibitor of EGFR activation mutation and tolerant mutation of EGFR T790M which has only limited activity against wild-type EGFR.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 249 | In Stock |
|
| 5MG | 197 | In Stock |
|
| 10MG | 312 | In Stock |
|
| 25MG | 525 | In Stock |
|
| 50MG | 740 | In Stock |
|
| 100MG | 1014 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2065 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHS-10296
-
NoteResearch use only, not for human use.
-
Brief DescriptionHs-10296 is an inhibitor of EGFR activation mutation and tolerant mutation of EGFR T790M which has only limited activity against wild-type EGFR.
-
DescriptionHs-10296 is an inhibitor of EGFR activation mutation and tolerant mutation of EGFR T790M which has only limited activity against wild-type EGFR.
-
In VitroHS-10296 is an orally available inhibitor of the epidermal growth factor receptor (EGFR) mutant form T790M, with potential antineoplastic activity, which canbe used to treat NSCLC. Additionaly, HS-10296 could also inhibit other EGFR sensitive mutations, including G719X, del19, L858R and L861Q.
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR (E746_A750/T790M)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1899921-05-1
-
Formula Weight525.66
-
Molecular FormulaC30H35N7O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (190.24 mM);Ethanol:6 mg/mL (11.41 mM);Water:Insoluble
-
SMILESCOc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc1nccc(n1)-c1cn(C2CC2)c2ccccc12
-
Chemical NameN-(5-((4-(1-cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Daphnetin
Daphnetin, a natural coumarin derivative, is a protein kinase inhibitor, inhibits EGFR, PKA and PKC with IC50 of 7.67 μM, 9.33 μM and 25.01 μM, respectively, also known to exhibit anti-inflammatory and anti-oxidant activities.
-
Lifirafenib
Lifirafenib is a potent inhibitor of RAF family kinases and EGFR in biochemical assays with IC50 of 23, 29 and 495 nM for the recombinant BRAFV600E kinase domain, EGFR and EGFR T790M/L858R mutant respectively.
-
Naquotinib mesylate
Naquotinib (ASP-8273) is a potent, irreversible, mutant-selective inhibitor of EGFR.
Cart
sales@molnova.com